If you are on Medicare and trying to figure out the cost of Xarelto, you have probably seen the headline: Medicare negotiated the price down to $197. Then you got to the pharmacy and were charged something else entirely. That gap is real, it is common, and almost nobody explains it plainly. SunnyPharma built this guide from official Medicare and manufacturer sources to do exactly that — show what Xarelto (rivaroxaban) actually costs on Medicare in 2026, why your pharmacy price may differ from the negotiated number, and the concrete steps that lower what you pay.
The single most important thing to know up front: the $197 figure is what the government pays, not necessarily your copay — and there are several legitimate ways to bring your cost down, including a new annual cap on what you can spend. For decisions about your treatment, your clinician and your Part D plan are the right sources; this guide helps you ask the right questions.
- $197 is the negotiated price (what Medicare pays), not automatically your copay
- Most enrollees pay ~$30–$50/month once past the deductible, depending on plan tier
- New annual cap: your total Part D out-of-pocket is limited to $2,100 for the year
- Extra Help (LIS) can cut a brand copay to about $12.65/month or less if you qualify
- Coupons and the withMe card don’t work with Medicare — but the payment plan does
- Never stop over cost: Xarelto has a boxed warning about clot and stroke risk if stopped early
Is the $197 Negotiated Price What You Actually Pay?
Usually not directly — and this is the heart of the confusion. The $197 is the Medicare-negotiated Maximum Fair Price for a 30-day supply of Xarelto, effective January 1, 2026, under the Inflation Reduction Act — about a 62% cut from the prior list price. It is the amount Medicare pays. What you pay at the counter is set by your individual Part D plan, and it moves through the year depending on which coverage phase you are in.
Think of your Part D year in phases. First you may owe a deductible (up to $615 in 2026) before your plan starts sharing costs — and during that phase your out-of-pocket can look much higher than $197. After the deductible, you pay your plan’s copay or coinsurance for Xarelto based on its formulary tier. And once your total spending hits the $2,100 annual cap, you pay nothing more for covered drugs for the rest of the year.
Why Your Pharmacy Charges More — and How to Diagnose It
If your pharmacy quote is higher than you expected, it is almost always explained by one of a few things. Work through them in order — this is the part most cost guides skip.
- You are still in the deductible phase. Early in the calendar year, before you have met your plan’s deductible (up to $615), you may pay the full negotiated price or more. This resets every January, which is why Xarelto often feels most expensive in the first months of the year.
- Xarelto is on a higher formulary tier in your plan. Two plans can cover the same drug at very different copays. Ask your plan which tier Xarelto is on and what the copay or coinsurance is for that tier.
- You are at an out-of-network or non-preferred pharmacy. Many Part D plans have “preferred” pharmacies with lower copays. The same prescription can cost less across the street.
- Your plan changed for 2026. Plans send an Annual Notice of Change each fall. If your tier or copay shifted, your cost did too.
The one call to make: phone the member-services number on your Part D card and ask three things — “Which coverage phase am I in right now?”, “What tier is Xarelto on, and what’s my copay in that tier?”, and “Is there a preferred pharmacy where it costs less?” Those three answers explain almost any surprising price.
How to Lower the Cost of Xarelto on Medicare
Here is what genuinely works for Medicare beneficiaries, in roughly the order most people should consider it. 2026 added real protection that did not exist before.
1. Lean on the new Part D out-of-pocket cap
This is the biggest change. Your total out-of-pocket for all Part D drugs is now capped at $2,100 for the year. Once you reach it, Xarelto and your other covered drugs cost you $0 for the rest of the year. For someone taking Xarelto long-term for atrial fibrillation, this caps your annual exposure in a way the old system never did.
2. Apply for Extra Help (Low-Income Subsidy)
If your income and resources are limited, Extra Help can reduce a brand-name copay to about $12.65 per month or less. You apply through the Social Security Administration. Check eligibility even if you are unsure — the resource limits exclude your home and car, so more people qualify than expect to. For many beneficiaries struggling with Xarelto cost, this is the highest-impact single step.
3. Use the Medicare Prescription Payment Plan
This 2026 option lets you spread your out-of-pocket costs across the year in monthly installments instead of paying a large amount at once. It does not lower your total, but it smooths out an expensive deductible month. Enrollment is voluntary and free, through your Part D plan.
4. Compare plans at Open Enrollment
During Open Enrollment (October 15 to December 7), use Medicare’s Plan Finder to compare how different Part D plans cover Xarelto. Because tier placement drives your copay, switching to a plan that tiers Xarelto more favorably can change your annual cost meaningfully.
Never stop taking Xarelto because of cost. Xarelto carries an FDA boxed warning that stopping it early raises the risk of blood clots and stroke. If you cannot afford it, talk to your clinician or pharmacist before skipping or stopping doses — one of the pathways above almost always fits, and a clinician can discuss whether a different, lower-cost anticoagulant is appropriate rather than going without treatment.
What Doesn’t Work: Coupons and the withMe Card
One route you will see advertised everywhere is closed to you on Medicare: the manufacturer copay coupon or savings card, including the Xarelto withMe Savings Card. Federal anti-kickback law prohibits using a drug manufacturer’s copay assistance if you have Medicare, Medicaid, or other government insurance. Those cards are built for people with commercial (private) insurance only. If a site lists “manufacturer coupons” or the withMe card as a way to save on Xarelto with Medicare, that advice is simply wrong.
There is one nuance worth knowing. A pharmacy discount card (such as SingleCare or GoodRx) is different from a manufacturer copay card — it offers a cash price instead of using your insurance. You can legally use one, but only by paying cash for that fill and not running it through Medicare, and what you pay that way does not count toward your Part D out-of-pocket cap. For most Medicare beneficiaries, the negotiated price plus the cap is the better route; the discount card is a niche tool for specific situations.
Searching for a coupon and hitting this wall is exactly why this page exists. If that is you, the next step isn’t another coupon site — it’s checking your Extra Help eligibility and confirming your plan’s Xarelto tier. Those move your real cost; the coupon never could.
Don’t Count on a Generic to Rescue Your Medicare Cost
You may have heard a generic rivaroxaban arrived in 2025 — and hoped it would bring your Medicare cost down. For most Medicare patients, it won’t, at least not yet. The only generic approved so far is the 2.5 mg tablet, which is for coronary and peripheral artery disease. The 10, 15, and 20 mg doses used for atrial fibrillation, DVT, and PE remain brand-only, with no announced generic date.
So if you take Xarelto for an irregular heartbeat or a clot, there is no generic for your dose, and the reliable cost levers stay the same: the negotiated price, the Part D cap, and Extra Help. Don’t switch your dose to chase a generic price — that is a different strength for a different condition.
If You’re Not Yet on Medicare
If you are uninsured or between coverage, the route is different from the Medicare pathways above: the Johnson & Johnson Patient Assistance Foundation, through Janssen CarePath, provides Xarelto at no cost to qualifying patients who are uninsured or underinsured and meet income limits (jjpaf.org). That program is generally not for Medicare beneficiaries — which is the whole reason the Medicare-specific pathways exist as a separate track. Commercially insured patients, in turn, use the Xarelto withMe Savings Card, which is also closed to Medicare.
Related Anticoagulant Guides
For the bigger picture on anticoagulant costs and the coupon question specifically, start here.
Frequently Asked Questions
How much does Xarelto cost on Medicare in 2026?
It depends on your Part D plan. A Medicare-negotiated price of $197 for a 30-day supply took effect January 1, 2026, but that is the price the government pays, not automatically your copay. Most Part D enrollees pay somewhere around $30 to $50 per month for Xarelto once past the deductible, depending on their plan’s formulary tier. In 2026 the maximum Part D deductible is $615 and your total annual out-of-pocket for all Part D drugs is capped at $2,100, after which covered drugs cost you nothing for the rest of the year.
Is the $197 Xarelto negotiated price what I actually pay?
Usually not directly. The $197 figure is the Medicare-negotiated Maximum Fair Price — what the government pays for a 30-day supply starting in 2026, about a 62% cut from the prior list price. What you pay at the pharmacy is set by your specific Part D plan: your deductible, your plan’s formulary tier for Xarelto, and your coinsurance or copay. That is why some patients see headlines about $197 but are still charged more at the counter, especially early in the year before the deductible is met. Your annual out-of-pocket is capped at $2,100 across all Part D drugs.
Why is my pharmacy charging more than $197 for Xarelto?
A few reasons. If you have not yet met your Part D deductible (up to $615 in 2026), you may pay the full negotiated price or more until coverage kicks in. After the deductible, your cost is your plan’s copay or coinsurance for Xarelto’s formulary tier, which can be higher or lower than $197. The negotiated price sets what Medicare pays, not your share. If the price seems wrong, ask your plan which coverage phase you are in and what tier Xarelto sits on, and confirm you are using a pharmacy in your plan’s preferred network.
How can I get help paying for Xarelto on Medicare?
Several legitimate routes exist. The biggest 2026 change is the Part D out-of-pocket cap of $2,100, which puts a hard ceiling on your yearly cost. If your income is limited, Medicare Extra Help (the Low-Income Subsidy) can cut your brand copay to about $12.65 per month or less. The Medicare Prescription Payment Plan lets you spread costs across the year. Note that manufacturer copay coupons and the Xarelto withMe Savings Card cannot be used with Medicare.
Can I use Medicare Extra Help for Xarelto?
Yes, if you qualify. Medicare Extra Help, also called the Low-Income Subsidy (LIS), helps people with limited income and resources pay Part D costs and can reduce a brand-name copay like Xarelto to about $12.65 per month or less. You apply through the Social Security Administration. It is worth checking eligibility even if you are unsure you qualify, because the resource limits exclude items like your home and car. For many Medicare beneficiaries struggling with Xarelto cost, Extra Help is the single highest-impact step.
Can I use a Xarelto coupon or the withMe card with Medicare?
No. Federal anti-kickback law prohibits using a manufacturer copay coupon or savings card — including the Xarelto withMe Savings Card — if you have Medicare, Medicaid, or other government insurance. Those cards are only for people with commercial (private) insurance. Medicare beneficiaries lower Xarelto costs through the negotiated price, the Part D out-of-pocket cap, Extra Help, and the Medicare Prescription Payment Plan instead.
What is the Medicare Prescription Payment Plan and does it lower my Xarelto cost?
The Medicare Prescription Payment Plan is a 2026 option that lets you spread your out-of-pocket drug costs across the calendar year in monthly installments instead of paying a large amount at the pharmacy at once. It does not reduce your total cost for the year, but it can make an expensive month — such as when you are still meeting your deductible — far more manageable. Enrollment is voluntary and free, and you sign up through your Part D plan.
Will a generic rivaroxaban lower my Medicare cost soon?
Probably not for your dose. The only generic rivaroxaban approved so far is the 2.5 mg tablet, which is for coronary and peripheral artery disease — not the 10, 15, or 20 mg doses used for atrial fibrillation, DVT, and PE, which remain brand-only with no announced generic date. So most Medicare beneficiaries taking Xarelto cannot rely on a generic to lower cost. The reliable levers are the negotiated price, the Part D out-of-pocket cap, and Extra Help, rather than waiting on a generic.
What happens if I stop taking Xarelto because of cost?
Stopping Xarelto because of cost is dangerous. Xarelto carries an FDA boxed warning that stopping it early raises the risk of blood clots and stroke. If cost is the barrier, talk to your clinician or pharmacist before skipping or stopping doses, and use the Medicare pathways first: the negotiated price, the Part D out-of-pocket cap, Extra Help, and the payment plan. A clinician can also discuss whether a different, lower-cost anticoagulant is appropriate rather than going without treatment.
How we reviewed this article:
SunnyPharma follows strict sourcing guidelines and relies on government agencies (CMS/Medicare, SSA, FDA, HHS) and official manufacturer program documentation. Dr. Swiggum’s review covers the clinical content; cost, coverage, and program details are drawn from official Medicare and manufacturer sources. We use only credible, verifiable sources to ensure accuracy.
Reviewer disclosure: Dr. Swiggum has disclosed financial relationships with Boehringer Ingelheim, Eli Lilly, Novartis, Novo Nordisk, Pfizer, and GSK, including work related to dabigatran, an anticoagulant that competes with the medication discussed here. Her review is limited to clinical accuracy and does not involve SunnyPharma’s editorial or cost-pathway recommendations.
Read our editorial policy →Sources & References
- Medicare — Drug Price Negotiation Program (Xarelto negotiated price effective 2026): cms.gov
- CMS — Draft CY 2026 Part D Redesign Program Instructions Fact Sheet (annual out-of-pocket threshold $2,100): cms.gov
- Medicare.gov — Costs for Medicare drug coverage (Part D), deductible and the out-of-pocket cap: medicare.gov
- Medicare.gov — Extra Help paying for Part D (Low-Income Subsidy): medicare.gov
- Social Security Administration — Extra Help with Medicare prescription drug costs: ssa.gov
- Medicare.gov — Medicare Prescription Payment Plan: medicare.gov
- Medicare.gov — Find a Medicare plan (Plan Finder): medicare.gov
- Johnson & Johnson Patient Assistance Foundation (Xarelto, uninsured patients): jjpaf.org
- Xarelto — official patient site and withMe Savings Card (Janssen): xarelto-us.com
- HHS Office of Inspector General — copay coupons and the federal anti-kickback statute: oig.hhs.gov
- FDA — Xarelto (rivaroxaban) Prescribing Information (boxed warning): accessdata.fda.gov
- NIH MedlinePlus — Rivaroxaban: medlineplus.gov